Showing results (191-200 of 446) with videos related to
Sort By:
Pageof 45
Expert Review of Vaccines|December 22, 2012
The history of MF59(®) adjuvant: a phoenix that arose from the ashesDerek T O'Hagan, Gary S Ott, Gary Van Nest, et al.Microbes and Infection|November 9, 2005
Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and CSusan W Barnett, Indresh K Srivastava, Jeffrey B Ulmer, et al.Vaccine|December 3, 2005
Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigensSusanne Jacobsson, Sara Thulin, Paula Mölling, et al.Pharmaceutics|October 27, 2022
2D NMR Analysis as a Sensitive Tool for Evaluating the Higher-Order Structural Integrity of Monoclonal Antibody against COVID-19Francesca Cantini, Emanuele Andreano, Ida Paciello, et al.Seminars in Respiratory and Critical Care Medicine|January 27, 2025
State of the Art and Emerging Technologies in Vaccine Design for Respiratory PathogensMatteo Ridelfi, Giulio Pierleoni, Vittoria Zucconi Galli Fonseca, et al.The Journal of Infectious Diseases|August 23, 2003
Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responsesRob Tierney, Anne-Sophie Beignon, Rino Rappuoli, et al.Vaccine|October 4, 2005
Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challengeSukumar Pal, Ellena M Peterson, Rino Rappuoli, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunityJes Dietrich, Claire Andersen, Rino Rappuoli, et al.Mbio|June 7, 2012
Escherichia coli: great diversity around a common coreDanilo G Moriel, Roberto Rosini, Kate L Seib, et al.Nature Reviews. Microbiology|March 24, 2004
SARS--beginning to understand a new virusKonrad Stadler, Vega Masignani, Markus Eickmann, et al.Pageof 45